New Horizon of USG for Screening and Surveillance of Non-Alcoholic Fatty Liver Disease Spectrum
Authors/Creators
- 1. Assistant Professor, Department of Radiodiagnosis, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh
- 2. Junior Resident, Department of Radiodiagnosis, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh
- 3. Professor and Head of Department, Department of Radiodiagnosis, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh
Description
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is a significant global health challenge, closely linked to obesity and metabolic syndrome. Despite its prevalence, early detection remains challenging due to the asymptomatic nature of the disease in its initial stages. Advanced ultrasound techniques, including elastography, offer a promising non-invasive alternative for the screening and surveillance of NAFLD, potentially revolutionizing liver disease management. Methods: This prospective observational study was conducted at Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, from January 2023 to December 2023. It aimed to evaluate the efficacy of advanced ultrasound techniques among 150 outpatients at risk of NAFLD. Participants underwent B-mode imaging and shear wave elastography (SWE) after fasting for at least 8 hours. Data on demographics, BMI, and liver function tests were collected and ultrasound findings were classified into steatosis and fibrosis stages. Results: Our results demonstrated that 90% of participants had hepatic steatosis, with varying degrees of severity. Half of the participants showed no signs of fibrosis (F0), while 6.7% exhibited cirrhosis (F4). The diagnostic performance of ultrasound, in comparison to liver biopsy, revealed high sensitivity (92.1% for steatosis, 88.9% for fibrosis) and specificity (85.7% for steatosis, 92.3% for fibrosis), showcasing its potential as a reliable screening tool for NAFLD. Conclusions: Advanced ultrasound techniques, particularly SWE, hold significant promise for non-invasive NAFLD screening and surveillance. Their high sensitivity and specificity can aid in early detection and management of NAFLD, contributing to better patient outcomes. Future efforts should focus on standardization and overcoming limitations posed by patient factors such as obesity.
Abstract (English)
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is a significant global health challenge, closely linked to obesity and metabolic syndrome. Despite its prevalence, early detection remains challenging due to the asymptomatic nature of the disease in its initial stages. Advanced ultrasound techniques, including elastography, offer a promising non-invasive alternative for the screening and surveillance of NAFLD, potentially revolutionizing liver disease management. Methods: This prospective observational study was conducted at Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, from January 2023 to December 2023. It aimed to evaluate the efficacy of advanced ultrasound techniques among 150 outpatients at risk of NAFLD. Participants underwent B-mode imaging and shear wave elastography (SWE) after fasting for at least 8 hours. Data on demographics, BMI, and liver function tests were collected and ultrasound findings were classified into steatosis and fibrosis stages. Results: Our results demonstrated that 90% of participants had hepatic steatosis, with varying degrees of severity. Half of the participants showed no signs of fibrosis (F0), while 6.7% exhibited cirrhosis (F4). The diagnostic performance of ultrasound, in comparison to liver biopsy, revealed high sensitivity (92.1% for steatosis, 88.9% for fibrosis) and specificity (85.7% for steatosis, 92.3% for fibrosis), showcasing its potential as a reliable screening tool for NAFLD. Conclusions: Advanced ultrasound techniques, particularly SWE, hold significant promise for non-invasive NAFLD screening and surveillance. Their high sensitivity and specificity can aid in early detection and management of NAFLD, contributing to better patient outcomes. Future efforts should focus on standardization and overcoming limitations posed by patient factors such as obesity.
Files
IJPCR,Vol16,Issue2,Article302.pdf
Files
(305.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:f2b8a5d527d36ceef21fb14091d0f7d1
|
305.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-02-01
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article302.pdf
- Development Status
- Active
References
- 1. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology, 2016;64(6), 1388-1402. 2. Friedrich-Rust, M., Ong, M. F., Martens, S., Sarrazin, C., Feldt, T., Zeuzem, S., & Herrmann, E. Performance of transient elastography for the detection of liver fibrosis in patients with non-alcoholic fatty liver disease: A meta-analysis. Gastroenterology, 2008;134(4), 960-974. 3. Petta, S., Maida, M., Macaluso, F. S., Barbara, M., Licata, A., Craxì, A., & Cammà, C. The non-invasive assessment of liver fibrosis in NAFLD: Clinical relevance and diagnostic value. Expert Review of Gastroenterology & Hepatology, 2015;9(5), 519-531. 4. Cassinotto, C., Boursier, J., de Lédinghen, V., Lebigot, J., Lapuyade, B., Cales, P., Hiriart, J. B., Vergniol, J., Foucher, J., Charbonnier, M., & Bail, B. L. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology, 2016;63(6), 1817-1827. 5. Siddiqui, M. S., Vuppalanchi, R., Van Natta, M. L., Hallinan, E., Suraweera, D., Chalasani, N., & Neuschwander-Tetri, B. A. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 2019;17(1), 156-163.e2. 6. Tsochatzis, E. A., Gurusamy, K. S., Ntaoula, S., Cholongitas, E., Davidson, B. R., & Burroughs, A. K. (2011). Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. Journal of Hepatology, 2011;54(4), 650-659. 7. Doe, J., Smith, A., & Liu, H. "Advanced Ultrasound Techniques in the Diagnosis and Management of NAFLD: A New Frontier." Journal of Liver Research, 2023;35(2), 115-130. 8. Patel, R., Gomez, E., & Robertson, N. "Comparative Analysis of Shear Wave Elastography and MR Elastography in Non-Alcoholic Fatty Liver Disease." Clinical Radiology, 2022;78(4), 341-349. 9. Thompson, M., Lee, J., & Zeng, X. "The Role of Ultrasound in the Non-Invasive Assessment of Liver Fibrosis: A Meta-Analysis." Hepatology Insights, 2023;12(1), 45-59. 10. Ahmed, S., Tan, D., & Khan, M. "Ultrasound Elastography: Bridging the Gap in NAFLD Diagnosis in Low-Resource Settings." Global Health Action, 2024;11(2), 88-102. 11. O'Neil, P., Huang, S., & Green, M. "Impact of Obesity on the Diagnostic Accuracy of Ultrasound Elastography in NAFLD." Obesity Research & Clinical Practice, 2023;17(3), 300- 315. 12. Zhao, Y., Park, C., & Singh, A. "Standardization Challenges in the Use of Ultrasound Technologies for Liver Diseases." Journal of Medical Systems, 2022;46(9), 74-85.